Shah Parag P, Beverly Levi J
James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Department of Medicine, Division of Hematology and Oncology, University of Louisville School of Medicine, Louisville, KY, USA.
Oncotarget. 2015 Jul 10;6(19):17725-37. doi: 10.18632/oncotarget.3918.
Valosin-containing protein (VCP), also called p97, is a AAA+ ATPase that has been shown to be involved in endoplasmic reticulum-associated protein degradation (ERAD), mitochondria quality control and vesicle transport. We and others have previously found that disruption of VCP is sufficient to cause endoplasmic reticulum (ER) stress. We observed that induction of ER stress either following siRNA mediated loss of VCP or inhibition of VCP with eeyarestatin I potently activates an EMT-like state in cells. Interestingly, both ER stress and EMT are reversible events. Further, brief treatment of cells with eeyarestatin I increases EMT markers, and migratory and invasive properties of lung cancer cells. By examining primary lung adenocarcinoma patient samples we find that the VCP locus is heterozygously lost in nearly half of lung adenocarcinomas and VCP protein expression is decreased in nearly all primary lung tumors. Further, primary lung adenocarcinomas have increased ER stress and EMT markers. These observations have potential clinical relevance because increased ER stress and EMT markers are known to contribute to chemoresistance and poor survival of patients with lung adenocarcinoma.
含缬酪肽蛋白(VCP),也称为p97,是一种AAA + ATP酶,已被证明参与内质网相关蛋白降解(ERAD)、线粒体质量控制和囊泡运输。我们和其他人之前发现,VCP的破坏足以引起内质网(ER)应激。我们观察到,在siRNA介导的VCP缺失后或用依匹他汀I抑制VCP后诱导ER应激,可有效激活细胞中的上皮-间质转化(EMT)样状态。有趣的是,ER应激和EMT都是可逆事件。此外,用依匹他汀I短暂处理细胞可增加EMT标志物以及肺癌细胞的迁移和侵袭特性。通过检查原发性肺腺癌患者样本,我们发现VCP基因座在近一半的肺腺癌中杂合缺失,并且几乎所有原发性肺肿瘤中VCP蛋白表达均降低。此外,原发性肺腺癌具有增加的ER应激和EMT标志物。这些观察结果具有潜在的临床相关性,因为已知增加的ER应激和EMT标志物会导致肺腺癌患者的化疗耐药性和不良生存率。